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Generation of a platform strain for ionic 
liquid tolerance using adaptive laboratory 
evolution
Elsayed T. Mohamed1, Shizeng Wang3,4,5, Rebecca M. Lennen1, Markus J. Herrgård1, Blake A. Simmons3,4, 
Steven W. Singer3,4 and Adam M. Feist1,2* 
Abstract 
Background: There is a need to replace petroleum-derived with sustainable feedstocks for chemical production. Cer-
tain biomass feedstocks can meet this need as abundant, diverse, and renewable resources. Specific ionic liquids (ILs) 
can play a role in this process as promising candidates for chemical pretreatment and deconstruction of plant-based 
biomass feedstocks as they efficiently release carbohydrates which can be fermented. However, the most efficient 
pretreatment ILs are highly toxic to biological systems, such as microbial fermentations, and hinder subsequent bio-
processing of fermentative sugars obtained from IL-treated biomass.
Methods: To generate strains capable of tolerating residual ILs present in treated feedstocks, a tolerance adaptive 
laboratory evolution (TALE) approach was developed and utilized to improve growth of two different Escherichia coli 
strains, DH1 and K-12 MG1655, in the presence of two different ionic liquids, 1-ethyl-3-methylimidazolium acetate 
 ([C2C1Im][OAc]) and 1-butyl-3-methylimidazolium chloride  ([C4C1Im]Cl). For multiple parallel replicate populations 
of E. coli, cells were repeatedly passed to select for improved fitness over the course of approximately 40 days. Clonal 
isolates were screened and the best performing isolates were subjected to whole genome sequencing.
Results: The most prevalent mutations in tolerant clones occurred in transport processes related to the functions 
of mdtJI, a multidrug efflux pump, and yhdP, an uncharacterized transporter. Additional mutations were enriched in 
processes such as transcriptional regulation and nucleotide biosynthesis. Finally, the best-performing strains were 
compared to previously characterized tolerant strains and showed superior performance in tolerance of different IL 
and media combinations (i.e., cross tolerance) with robust growth at 8.5% (w/v) and detectable growth up to 11.9% 
(w/v)  [C2C1Im][OAc].
Conclusion: The generated strains thus represent the best performing platform strains available for bioproduction 
utilizing IL-treated renewable substrates, and the TALE method was highly successful in overcoming the general issue 
of substrate toxicity and has great promise for use in tolerance engineering.
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Background
There is a need to replace chemical and fuel produc-
tion from fossil feedstocks with carbon neutral sources 
to retain the natural cycle of carbon emission and 
assimilation. Certain biomass feedstocks can play a 
major part in this need as they are abundant, diverse, 
and renewable. These biomass feedstocks include gen-
eral plant-based materials like energy crops, crop resi-
dues, wood, wood residues, and grasses. Most of these 
materials have intrinsic value alongside with the added 
possibility of use as biomaterials [1]. Biomass feed-
stocks, however, possess a low energy density requiring 
a greater quantity of them to meet market demands [2]. 
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Therefore, innovative approaches are necessary to make 
biomass feedstocks viable carbon sources to replace fossil 
feedstocks.
Lignocellulosic biomass can serve as a carbon neutral 
and abundant feedstock for bioprocesses [3]. In order to 
utilize lignocellulosic biomass for biochemical conver-
sion in biorefineries, a pretreatment process is needed 
to remove the physical and chemical barriers to fully uti-
lize the sugar substrates. The main aim of pretreatment 
is to increase the accessibility of cellulose, which then 
can be subjected to enzymatic saccharification to release 
fermentable sugars. This can be achieved through dis-
solution of hemicellulose and/or lignin, which coat the 
surface of cellulose [4]. There are several approaches for 
pretreatment of lignocellulosic biomass which include 
physical and chemical methods, but one of the most 
effective approaches is to directly release monomeric 
sugars through treatment with Ionic liquids (ILs) [5]. 
ILs are effective solvents for deconstruction and result 
in generating sugar feedstocks without significant loss of 
sugars due to degradation [4, 6, 7].
Despite its efficacy, IL pretreatment has some limita-
tions, as some amounts of ILs remain from the pretreat-
ment and these are often highly toxic to microbes used 
in downstream fermentation processes. Typically, a 
deconstruction hydrolysate has around 0.2–5% (w/v) of 
ionic liquid after the pretreatment [8]. One practice to 
overcome toxicity is to wash the pretreatment several 
times mostly with water, but this process adds significant 
purification costs [6]. Thus, an alternate approach to deal 
with toxicity by developing microbial platform strains 
that can tolerate residual ILs is needed. Limited tolerance 
toward ILs has been previously achieved using a range of 
techniques including rational design [8–10] and adaptive 
laboratory evolution (ALE) [11]. The rationally-designed 
strains generally introduced a non-native efflux pump for 
ILs which exerts a metabolic burden on the cells and a 
need for tight expression control. The previous ALE study 
showed promise for the approach [11], but the scope was 
limited to one IL, utilized a rich undefined media, and 
no genetic basis for the improved performance was pre-
sented. Nonetheless, this preliminary work revealed an 
opportunity to apply ALE for IL tolerance and can be 
used for comparison.
In the present work, the problem of IL toxicity is 
addressed using a systematic ALE strategy, Toler-
ance adaptive laboratory evolution (TALE), to gener-
ate Escherichia coli (E. coli) strains that were highly 
tolerant to the presence of ILs. The TALE method differs 
from previous efforts in that dynamic control is used to 
increase the amount of stress applied to cells to keep a 
strong selection pressure without crashing cultures due 
to overstressed growth conditions. The TALE approach 
for IL tolerance employed in the present study has two 
major advantages compared to manual ALE work (e.g., 
[11]). First, the TALE approach significantly improved 
fitness and final cell density in higher IL concentra-
tions than the manual ALE approach. Additionally, the 
IL cross-tolerance phenotype exhibited by the best per-
forming strains can expand the application of TALE-
derived strains. Finally, these results were obtained over 
a significantly shorter time frame (40 vs 90 days) using an 
automated platform for performing TALE (details of the 
improvement are provided below).
In this study, two biotechnologically-relevant strains of 
E. coli (K-12 MG1655 and DH1) were exposed to increas-
ing concentrations of two ILs; 1-butyl-3-methylimidazo-
lium chloride and 1-ethyl-3-methylimidazolium acetate. 
Both of these targeted ILs are promising solvents for bio-
mass pretreatment and were considered as a good can-
didates for IL-pretreated biomass [5, 7]. The exposure 
was performed over repeated exponential batch growth 
in parallel biological replicates. The evolved populations 
were screened and individual isolates were re-sequenced 
to identify key causal mutations. Selected isolates were 
compared against rationally-designed strains previously 
demonstrated to possess IL tolerance [8, 12]. The best 
performing strains showed markedly improved toler-
ance toward higher concentrations of ILs over rationally 
designed strains. The key mutations identified in this 




Two E. coli strains were utilized: DH1 (ATCC 33849) and 
K-12 MG1655 (ATCC 47076). Two ionic liquids were uti-
lized. 1-Butyl-3-methylimidazolium chloride  ([C4C1Im]
Cl) was purchased from Sigma-Aldrich (Basionics ST 
70, BASF), and 1-ethyl-3-methylimidazolium acetate, 
 ([C2C1Im][OAc]), was purchased from IOLITEC ionic 
Liquids Technologies GmbH (Heilbronn, Germany). 
Chemicals and components of the medium used for 
selecting the best performing strains were purchased 
from Sigma-Aldrich (St. Louis, USA) or VWR (West 
Chester, USA) unless otherwise noted.
M9 glucose medium contained 2  g/L glucose, 1× M9 
salts, 2  mM  MgSO4, 100  µM  CaCl2 and 1× trace ele-
ments and Wolfe’s vitamin solution. Composition of 
10× M9 salts solution consisted of 68  g/L  Na2HPO4 
anhydrous, 30  g/L  KH2PO4, 5  g/L NaCl, and 10  g/L 
 NH4Cl dissolved in Milli-Q filtered water and auto-
claved. M9 trace elements was a 2000× solution con-
taining of 3.0  g/L  FeSO4·7H2O, 4.5  g/L  ZnSO4·7H2O, 
0.3  g/L  CoCl2·6H2O, 0.4  g/L  Na2MoO4·2H2O, 4.5  g/L 
 CaCl2·H2O, 0.2 g/L  CuSO4·2H2O, 1.0 g/L  H3BO3, 15 g/L 
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disodium ethylene-diamine-tetra-acetate, 0.1  g/L KI, 
0.7 g/L  MnCl2·4H2O and concentrated HCl dissolved in 
Milli-Q filtered water and sterile filtered. The final con-
centrations of the vitamin mix and trace elements in the 
M9 medium were 1×.
Screening for tolerance in wild type strains
The two E. coli strains, DH1 and K-12 MG1655, were 
initially screened for their tolerance towards different 
concentrations of each IL in order to choose the start-
ing concentration where the growth rate and final optical 
density were higher. A description of tolerance screen-
ing and tolerance phenotype in wild type strains (Addi-
tional file  2: Table S1). Cells from an overnight culture 
in LB medium were inoculated into cylindrical tubes 
containing 15  mL  M9 glucose supplemented with vary-
ing concentrations of each ionic liquid. Inoculated tubes 
were temperature-controlled at 37  °C and fully aerated. 
Growth rates and final optical density were determined 
from 600  nm wavelength  (OD600) measurements on a 
sunrise plate reader (Tecan, Männedorf, Switzerland).
Adaptive laboratory evolution of IL tolerance
The bacterial cells were adaptively evolved under batch 
fermentation in M9 glucose supplemented with the 
initial ionic liquid concentration listed in Table  1, with 
increasing concentration of ILs applied over the course of 
the ALEs. Cells were serially passaged during exponen-
tial growth for approximately 40 days using an automated 
liquid-handler platform [13]. Pre-cultures for inoculating 
the starting culture were grown in M9 glucose and 150 µL 
of each pre-culture was used to inoculate each independ-
ent replicate with a working volume of 15 mL. Cells were 
cultured at 37  °C.  OD600 was measured at a time deter-
mined algorithmically and once  OD600 reached approxi-
mately  OD600 0.3, 150 µL was passed into a new tube with 
a fresh media containing ILs and a total working volume 
of 15 mL (i.e., a 1:100 ratio). The commonly experienced 
exponential growth phase was from time of inocula-
tion to approximately  OD600 0.3 and the maximum final 
 OD600 was approximately 0.4, thus the cells were passed 
during the exponential phase. The  OD600 was measured 
by a Sunrise Plate Reader (Tecan Inc., Switzerland) and 
the common ratio between the plate reader  OD600 and 
a benchtop spectrophotometer with a 1 cm path length 
is 4.2. Growth rates were determined by calculating the 
slope of the semi-log plot of log OD versus time using 
linear regression with the Polyfit function in MATLAB 
(The Mathworks Inc., Natick, Massachusetts). When 
increased growth rate was achieved after a defined period 
Table 1 Growth phenotypes for  E. coli K-12 MG1655 and  DH1 evolved populations endpoints on  ILs  ([C4C1Im]Cl 
and  [C2C1Im][OAc])
a Initial and final growth rates were calculated for the whole population from the first and last 3 flasks of each corresponding population endpoints, respectively













[C4C1Im]Cl MG1655 ALE #1 1.5 0.3 6.2 0.2 ± 0.02 4.7 62
MG1655 ALE #2 1.5 0.2 6.2 0.1 ± 0.03 4.7 67
MG1655 ALE #3 1.5 0.3 4.9 0.3 ± 0.12 3.4 63
MG1655 ALE #4 1.5 0.2 5.6 0.1 ± 0.05 4.1 84
5.7 ± 0.6 0.2
DH1 ALE #5 1.5 0.2 4.8 0.2 ± 0.05 3.3 61
DH1 ALE #6 1.5 0.2 5.6 0.3 ± 0.08 4.1 72
DH1 ALE #7 1.5 0.2 5.6 0.1 ± 0.01 4.1 79
DH1 ALE #8 1.5 0.2 4.2 0.2 ± 0.02 2.7 50
5.0 ± 0.6 0.2
[C2C1Im][OAc] MG1655 ALE #9 2 0.2 5.9 0.1 ± 0.00 3.9 86
MG1655 ALE #10 2 0.2 5.9 0.1 ± 0.04 3.9 87
MG1655 ALE #11 2 0.2 6.5 0.2 ± 0.00 4.5 91
MG1655 ALE #12 2 0.2 5.9 0.1 ± 0.01 3.9 92
6.1 ± 0.3 0.1
DH1 ALE #13 1 0.1 4.5 0.1 ± 0.06 3.5 77
DH1 ALE #14 1 0.1 4.5 0.1 ± 0.02 3.5 92
DH1 ALE #15 1 0.2 4.5 0.2 ± 0.01 3.5 79
DH1 ALE #16 1 0.2 5.2 0.2 ± 0.02 4.2 88
4.6 ± 0.3 0.2
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of time at a particular concentration, the ionic liquid con-
centration was increased. This process was repeated until 
a significant increase in tolerance was achieved. Periodi-
cally, samples were frozen in a 25% v/v glycerol solution 
and stored at − 80 °C for further use.
Primary screening
Evolved isolates were screened for growth proper-
ties (growth rate, lag time, and final  OD600) on selected 
concentrations (Table  1) of  [C4C1Im]Cl and  [C2C1Im]
[OAc] using a Growth Profiler (EnzyScreen BV, Leiden, 
Netherlands). Populations from endpoint evolutions 
were plated on LB agar plates and ten individual colo-
nies derived from each population were screened at the 
maximum concentration for which robust growth rates 
were achieved during the evolution. Colonies from wild 
type starting strains, E. coli K-12 MG1655 and DH1, were 
used as a control for the primary screening. Selected iso-
lates were inoculated into 500 µL M9 glucose medium in 
deep well plates and incubated in a plate shaker at 37 °C 
and 300  rpm shaking. Later, cells were diluted 10× in 
M9 glucose medium, from which 30 µL was transferred 
to clear-bottom 96 half-deepwell plates (EnzyScreen BV, 
Leiden, Netherlands) containing M9 glucose medium 
with either of the two ionic liquids, such that the final 
concentration was equal to the concentrations listed in 
Table 1. Cryogenic stocks of the pre-culture plates were 
stored in 96-well plates. The half-deepwell plates were 
incubated at 37 °C with 225 rpm shaking in the Growth 
Profiler, with scans recorded at 15  min intervals. Green 
pixel (G) values extracted from the 1  mm diameter cir-
cular areas in the center of each well in the images were 
converted to  OD600 values using a calibration between 
 OD600 (1  cm path-length) and G values. The resulting 
growth curves for each isolate, Additional file  2: Figure 
S1, were inspected for those exhibiting robust growth 
or unique growth profiles such as exhibiting reduced 
lag-times, increased final densities, and increased in the 
apparent growth rates. Ten isolates from each popula-
tion were grouped according to their similarities between 
these parameters.
Secondary screening of TALE isolates
Three individual isolates chosen from primary screen-
ing from each population underwent secondary screen-
ing, where biological replicates were analyzed. The IL 
concentration was lowered to the average concentration 
used in the primary screen for all clones. These adjusted 
IL concentrations for both E. coli K-12 MG1655 and DH1 
are listed in Additional file  2: Tables S2 and S3, respec-
tively. Selected isolates from the primary screening were 
steaked out on LB agar from the cryogenic stock plates 
stored for primary screening. Three individual colonies 
from each isolate were inoculated as biological replicates 
into 96-well deepwell plates containing 500 µL M9 glu-
cose and grown overnight. The next day, cryogenic stocks 
were prepared as described for primary screening. Each 
well from the overnight culture were inoculated to a low 
 OD600 (1:100 dilution) in M9 glucose medium with the 
specified IL concentration, and growth was monitored 
until stationary phase was reached. Growth rates were 
calculated as described previously, and the average values 
of the three cultures were determined.
Re‑sequencing of improved IL tolerance clones
Sequencing was performed on an Illumina NextSeq 
(Model 550) Sequencer (San Diego, CA). A total of 45 
isolates were re-sequenced. Selected colonies were iso-
lated on LB agar plates, genomic DNA was extracted 
using  PureLink® Genomic DNA Kits (Invitrogen, CA). 
The quality of extracted DNA was assessed with UV 
absorbance ratios using a nano drop. Concentration of 
DNA was quantified using Qubit ds-DNA high sensitiv-
ity assay. Paired-end resequencing libraries were gener-
ated using a 300 cycle (150 bp × 2) kit from Illumina (San 
Diego, CA) with loading concentration on Nextseq 1.2 
pico-Molar with 1% PhiX spike (Illumina, San Diego, CA) 
of input DNA total. Re-sequencing data were analyzed 
using a customized script based on the Breseq version 
0.30.1 [14] to map sequence reads and identify mutations 
relative to the reference strain. The average coverage for 
each isolate was typically over 400 (a relatively high cov-
erage for clonal sequencing). The genomes of the evolved 
strains were sequenced and mapped to the genome of the 
parent strains (NCBI Accession Numbers NC_000913.3 
and NC_017625.1) to examine mutations.
Criteria for choosing the best‑performing clones from the 
secondary screen
Additional file 2: Figure S2 summarizes the method used 
to choose representative clones from each genotypic-
clustered set. These representative clones were being 
used to screen enhanced performance for each clone. For 
each genotypic-clustered set, if the physiology was the 
same with a %RSD (relative standard deviation)  ≤  20% 
variability in growth rate and final OD, the selection was 
made based on the clone with the fastest growth rate 
and highest final OD with least variability. Alternatively, 
clones with the fastest growth rate and highest final OD 
were selected.
Comparing TALE best‑performing clones 
to rational‑designed strains
The medium used was a modified M9 glucose contain-
ing 4  g/L glucose. The appropriate amounts of antibiot-
ics (100 mg/L carbenicillin and 50 mg/L kanamycin) were 
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added when needed.  [C2C1Im][OAc] (BASF, Germany) 
was added to the medium as indicated. Seed cultures in 
LB medium were grown overnight and diluted 1:50 into 
M9 glucose medium (modified to contain 4 g/L glucose, 
with 100  mg/L carbenicillin and 50  mg/L kanamycin 
added when needed) containing varying concentrations 
of  [C2C1Im][OAc] or  [C2C1Im]Cl (BASF, Germany). Cul-
tures were grown in 96 well plates (BD Falcon) on a Tecan 
F-200 Pro microtiter plate reader (Maennedorf, Swit-
zerland) or in 250 mL flat-bottom flasks at 200 rpm and 
37 °C. The absorbance of samples from 250 mL flat-bot-
tom flasks was measured at 600 nm using a Spectramax 
M2 spectrophotometer (Molecular Devices, USA). Ini-
tially, selected clones were screened in  [C2C1Im][OAc] 
to determine levels of tolerance to a IL not used for the 
ALE process (i.e., cross-tolerance), then best-performing 
clones were used for the comparison in  [C2C1Im][OAc] 
and  [C2C1Im]Cl in either M9 or LB medium to under-
stand performance in both a minimal defined and rich 
undefined media. The parent strain E. coli K-12 MG1655 
was used as a control. The IL tolerant strains JBEI-10101 
[8] and JBEI-13314 [12] were also tested for comparison.
Results
A tolerance adaptive laboratory evolution (TALE) experi-
ment was utilized to generate strains which could toler-
ate toxic concentrations of similarly close ionic liquids 
(ILs) and identify mutations which likely confer a fitness 
advantage under more economically advantageous bio-
processing conditions, i.e., pretreated biomass solution 
containing some ILs. Two different E. coli strains were 
chosen for the study (K-12 MG1655 and DH1) as well as 
two types of ILs; 1-butyl-3-methylimidazolium chloride 
 ([C4C1Im]Cl) and 1-ethyl-3-methylimidazolium acetate 
 ([C2C1Im][OAc]). The E. coli strains were chosen as they 
are often used in bioprocessing applications [15, 16] and 
as the adaptive responses of K-12 MG1655 toward mini-
mal medium growth is known [17]. IL pretreatment for 
biomass deconstruction has been demonstrated in sev-
eral studies as a promising approach to solubilize cellu-
losic polysaccharides, thereby increasing the enzymatic 
turnover of saccharification, and also reducing the for-
mation of inhibitory by-products [6, 18, 19].
Description of fitness changes during the TALE experiment
The process of TALE was successful in generating strains 
with increased tolerance to ILs. Four replicate popula-
tions of each E. coli strain were evolved on each of the 
ILs. The IL concentration was increased under continu-
ous exponential batch growth over the course of the 
experiment when an observed fitness over a threshold 
was achieved (i.e., a growth rate of ≥  0.15/h). During 
this period of time, each of the populations underwent 
a total number of cumulative cells divisions (CCD) of 
1.93  ×  1012, 2.73  ×  1012 for E. coli K-12 MG1655 and 
1.56 × 1012, 1.61 × 1012 CCD for DH1 populations with 
 [C4C1Im]Cl and  [C2C1Im][OAc], respectively (Additional 
file  2: Table S4). The use of CCD has previously been 
shown to be a meaningful measure of evolution time [20]. 
The observed growth rates during a representative TALE 
Fig. 1 Plots of population growth rate versus IL concentration over the course of two TALE experiments for increasing IL tolerance. a E. coli K-12 
MG1655 population ALE #1 evolved on glucose minimal medium with  ([C4C1Im]Cl) and, b E. coli DH1 population ALE #11 evolved on glucose mini-
mal medium with  ([C2C1Im][OAc]). Depicted are fitness trajectories and IL concentration versus cumulative cell divisions (CCD) experienced by the 
cultures for two out of the total sixteen individual experiments. IL concentration was increased step-wise when the growth rate for the population 
increased
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experiment as well as the initial and final IL concentra-
tions are shown in Fig. 1. Similar plots for the remaining 
populations are shown in Additional file 2: Figure S3.
The ability of K-12 MG1655 populations to adapt to 
increasing IL concentrations was superior to DH1 for 
both ionic liquids, with average final concentrations 
achieved of 5.7  ±  0.6% (w/v) and 6.1  ±  0.3% (w/v) for 
MG1655 and 5.0 ± 0.6% (w/v) and 4.6 ± 0.3% (w/v) for 
DH1, with  [C4C1Im]Cl and  [C2C1Im][OAc], respectively 
(Table 1). During the TALE experiments, population fit-
nesses fluctuated in response to the concentration of IL 
added to media (Fig. 1). Additionally, applied IL concen-
tration increases were sometimes too large and resulted 
in ceased growth. In these instances, the concentration 
was adjusted back to the previous concentration in order 
to restore growth, and a smaller step change in concen-
tration was employed. Overall, there were approximately 
five increases in IL concentration for each experiment 
using an average step increase of 0.75% (w/v) over the 
current concentration. Each experiment contained an 
average of 67 flasks in  [C4C1Im]Cl and an average of 87 
flasks in  [C2C1Im][OAc]. Screening of the evolved popu-
lations was subsequently performed to understand the 
overall tolerance and performance of evolved isolates.
Screening of evolved isolates for improved tolerance
Isolates from evolved populations were screened for 
improved tolerance to ILs and to help identify causal 
mutations through genotype–phenotype relationships 
following resequencing. A primary screen was performed 
to establish whether selected isolates from each popu-
lation (10 isolates from each of 16 populations) could 
grow reproducibly in the average final IL concentration 
achieved during TALE (Table 1). From this analysis, three 
isolates from each population were selected for second-
ary screening and whole genome sequencing based on 
qualitative differences in the observed primary screen 
growth rates (Additional file  2: Figure S1). Additionally, 
isolates were selected that still exhibited tolerance but 
displayed unique growth phenotypes. Clones from one 
of the populations of DH1 on  [C4C1Im]Cl did not grow; 
therefore, this population was dropped from the analy-
sis (ALE #8). A total of 45 isolates were whole genome 
resequenced.
Whole genome resequencing and mutation analysis
Whole genome resequencing was used to determine the 
genetic basis of fitness tolerance phenotypes. Key muta-
tions were determined by comparing all of the clones 
and identifying genes, or genetic regions (i.e., inter-
genic regions) which had multiple unique mutations or 
were mutated across isolates from independent popula-
tions. Overall, there were 37 and 53 unique mutations 
identified for E. coli K-12 MG1655 and DH1, respectively. 
Each isolate had between 1 and 13, or 2 and 12 muta-
tions identified for MG1655 or DH1, respectively. There 
were three hyper-mutator isolates (1 from MG1655 and 
2 from DH1) identified. The MG1655 isolate had 267 
mutations, while the DH1 isolates had 39 ± 4 mutations, 
as compared to the average mutations 5 ± 4 for the non-
hypermutating clones from both strains with standard 
deviation shown between replicates. The hyper-mutator 
clone from MG1655 had two mutations in two different 
SOS genes, uvrA and uvrC, which are involved in DNA 
repair processes under stressed conditions [21] as well as 
an intragenic IS element mutation between fnr and ogt, 
where the later gene is a methyltransferase known to be 
involved in hypermutating phenotypes [22]. For the two 
DH1 hypermutator clones, it was not apparent which 
genes may have caused such phenotypes. Hypermutating 
clones were excluded from further analysis to simplify 
the genetic analysis and as they have a greater potential 
for instability when utilizing them as a platform strain.
Key mutations are presented in Table  2, which are 
defined as mutations in genes or regions that were found 
to be repeatedly mutated across different isolates of K-12 
MG1655, DH1, or in both strains. A full summary of 
mutations for each isolate are given in Additional file 1. 
The mutations were categorized as ‘combined’ or ‘strain-
specific’. Overall, there were two genetic regions identi-
fied as ‘combined’ mutations occurring in both strains. 
Further, there were four and six strain-specific key muta-
tions for MG1655 and DH1, respectively.
The first key mutation occurring in both strains was in 
the non-coding intergenic region between mdtJ and tqsA. 
Mutations in this region have been previously reported 
to improve tolerance of E. coli toward isobutanol [23]. 
The mdtJ gene encodes a component of a multidrug 
efflux pump that also physiologically exports spermidine 
[24]. Surprisingly, an identical deletion of Δ120 bp in the 
intergenic region, i.e., mdtJI promoter region, between 
the genes occurred in both of the strains. This deletion 
was found in every MG1655 clone isolated. The wide-
spread penetration of this mutation could be due the fact 
that this deletion was the easiest to loop out under IL or 
other stress conditions [23] or could be due to occur-
rence of this mutation in the seeding culture for the 
experiment (although it did occur in both K-12 MG1655 
and DH1). The other types of mutations in this region 
were structural changes in the tqsA gene—one was an 
intragenic in-frame ∆12  bp deletion, and the other was 
a ∆3035 bp deletion which included the pntB, and pntA 
genes located next to tqsA on the chromosome. The latter 
of these mutations is likely a loss of function mutation for 
tqsA. PntA and pntB, encode for the two subunits form-
ing pyridine nucleotide transhydrogenase enzyme [25] 
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and are important for redox balance in the cell [26, 27]. 
The tqsA gene encodes a transporter of quorum-sensing 
signal AI-2 which plays a role in control of biofilm for-
mation in E. coli K-12 by enhancing transport of autoin-
ducer-2 (AI-2) [28]. A ΔtqsA mutant was found to carry 
higher resistance to various drugs [28], which reveals 
a potentially tolerance role in the evolved strains in this 
study.
The second key mutation occurring in both strains 
was in yhdP, a gene encoding a putative transport 
protein [29]. A total of five unique mutations, all struc-
tural changes, were identified in yhdP—three in MG1655 
and two in DH1. These mutations were two out-of-frame 
short deletions, two IS mobile element insertions, and a 
short 7 bp duplication. All of these structural mutations 
suggest a loss of function. There are no previous studies 
examining the role of yhdP in tolerance, to the best of our 
knowledge, making this finding a novel discovery.
Strain-specific key mutations (Table 2) were also iden-
tified in MG1655 and DH1. In MG1655, three different 
Table 2 Key mutations categorized by those which repeatedly mutated (i.e., had multiple unique mutations in any ORF 
or genetic region) in K-12 MG1655, DH1, or those which were shared across the strains
Different unique mutations in the same gene or allele were identified in different clones across the different experiments. The mutations were categorized as 
‘combined’, i.e., identified in both strains, or ‘strain-specific’. B and E denotes  [C4C1Im]Cl and  [C2C1Im][OAc] IL, respectively, where MG denotes K-12 MG1655 strain
Strain Gene Mutation Mutation type Mutated allele function Strain IL observed Count
Combined mdtJ/tqsA Intergenic (− 56/− 237) Δ120 bp DEL Transporter MG B, E 23
tqsA/mdtJ Intergenic (− 239/− 54) Δ120 bp DEL Transporter DH1 B 5
tqsA Coding (857–868/1035 nt) Δ12 bp DEL Transporter MG B 6
pntA–tqsA Δ3035 bp DEL Transhydrogenase/transporter DH1 B 2
yhdP Coding (2440–2443/3801 nt) Δ2 bp DEL Transporter MG B 1
Coding (647/3801 nt) (TGGAGCC)1 → 2 INS Transporter MG B 4
Coding (200–201/3801 nt) IS5 (−) +4 bp MOB Transporter MG B 1
Coding (3102–3110/3801 nt) IS ele-
ment(+) +9 bp
MOB Transporter DH1 B 1
Coding (2887–2890/3801 nt) Δ4 bp DEL Transporter DH1 B 1
MG1655 rpoC P359L (CCA → CTA) SNP RNA synthesis MG B 4
F773Y (TTC → TAC) SNP RNA synthesis MG B 6
R1075S (CGT → AGT) SNP RNA synthesis MG B 1
cspC Coding (33–41/210 nt) IS1 (−) +9 bp MOB Stress protein MG B 1
Q37* (CAG → TAG) SNP Stress protein MG E 1
rpsG Coding (460/540 nt) Δ1 bp DEL Subunit of ribosome MG B 1
L157* (TTA → TGA) SNP Subunit of ribosome MG B 2
rph Pseudogene (667/669 nt) + C INS Nucleotide biosynthesis MG E 2
pyrE/rph Δ82 bp DEL Nucleotide biosynthesis MG B 5
DH1 rho G61E (GGA → GAA) SNP Transcription termination factor DH1 B 2
Y80H (TAC → CAC) SNP Transcription termination factor DH1 E 5
Y80C (TAC → TGC) SNP Transcription termination factor DH1 B 2
T406P (ACC → CCC) SNP Transcription termination factor DH1 E 4
fhuA Coding (337–479/2244 nt) Δ143 bp DEL Transport of ferrichrome DH1 E 1
Coding (1442/2244 nt) (GTCATAACGAC-
CGCCTAGGG)1 → 2
INS Transport of ferrichrome DH1 E 1
Coding (2107/2244 nt) Δ1 bp DEL Transport of ferrichrome DH1 B 2
Coding (2129/2244 nt) Δ1 bp DEL Transport of ferrichrome DH1 E 4
rcdA L55S (TTG → TCG) SNP Transcription regulator DH1 E 1
Coding (338–341/537 nt) IS element(+) 
+4 bp
MOB Transcription regulator DH1 E 1
purB K404T (AAG → ACG) SNP Nucleotide biosynthesis DH1 B 2
S21N (AGC → AAC) SNP Nucleotide biosynthesis DH1 E 1
gadE Coding (273–281/528 nt) IS element(-) 
+9 bp
MOB Transcriptional activator DH1 E 2
Coding (273–281/528 nt) IS element(+) 
+9 bp
MOB Transcriptional activator DH1 E 1
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coding mutations were identified in rpoC, encoding the 
β′ subunit of RNA polymerase. Prior ALE studies have 
identified rpoC coding mutations, which were found 
to both boost metabolic efficiency in glucose minimal 
medium [30] and improve growth at 42 °C [31, 32]. Prob-
able loss-of-function mutations (premature stop codon 
and IS element insertion) were identified in cspC (encod-
ing a stress protein of the CspA family). CspC is thought 
to stabilize rpoS mRNA when overexpressed [33] and 
to have activity as a transcription anti-terminator [34]. 
Mutations in this gene were previously found to play a 
role in stress responses [33]. Two different mutations 
occurred in the rpsG gene, encoding the essential S7 
subunit of the 30S ribosome. These were a Δ1  bp dele-
tion and a premature stop codon near the end of the 
gene. These mutations likely correct a defective 23 amino 
acid C-terminal extension to RpsG that occurs only in 
K-12 derived strains and that causes increased degrada-
tion of this protein. Similar mutations have previously 
been observed in MG1655 evolved for increased toler-
ance toward sodium cation [35]. Truncation of rpsG is 
thus likely a general stress coping mechanism. An ∆82 bp 
deletion was also found in the intragenic region between 
pyrE and rph and an insertion in rph was observed seven 
times in different clones. The rph gene encodes for an 
RNase PH [36], where pyrE encodes an orotate phospho-
ribosyltransferase [37]. Related deletion mutations were 
reported in different ALE studies including adaptation to 
lactate, minimal glucose medium, and high temperature 
(42 °C) [17, 30, 32]. The wild type strain E. coli K-12 has 
a frameshift mutation in rph which leads to pyrimidine 
starvation on minimal media due to resulting low levels 
of orotate phosphoribosyltransferase encoded by pyrE 
[38]. It appears that these mutations can be attributed 
to a 15% growth advantage by alleviation of defects in 
pyrimidines biosynthesis [39], and these mutations are 
predominantly general adaptations to growth on mini-
mal medium. Interestingly, in DH1, mutations were not 
found in rpoC, rpsG, or pyrE/rph, with mutations in the 
latter two regions serving to correct metabolic and ribo-
somal protein defects that are present in all K-12 strains, 
including DH1.
Strain-specific mutations in DH1 included genes 
involved in the processes of transcriptional activation 
and transportation. In 13 isolates, rho, encoding the 
Rho transcription terminator with annotated function 
as transcription termination factor Rho [40], all con-
tained coding SNPs. Coding mutations in Rho have pre-
viously been observed as a major contributor to ethanol 
tolerance [41, 42], and have been found to reduce the 
rate of Rho-dependent transcription termination in an 
ethanol-tolerant mutant [42]. The fhuA gene (encoding 
a ferrichrome outer membrane transporter) had several 
unique mutations in eight different isolates, including 
two unique ∆1  bp deletions, a ∆143  bp deletion, and a 
20  bp short insertion. Additionally, two unique mobile 
element insertions were found between three isolates 
in gadE (encoding the GadE transcriptional activator), 
and a coding SNP and a mobile element insertion were 
found in two isolates in rcdA (encoding the RcdA tran-
scriptional activator). Interestingly, deletion of rcdA was 
previously found to improve tolerance of DH1 toward IL 
[12]. Finally, two different coding SNPs in purB (encoding 
adenylosuccinate lyase) were found in three isolates.
Secondary screening of the evolved clones
A secondary screen was performed to generate quantita-
tive data on the resequenced isolates after their genetic 
bases had been determined (see “Methods”). Rese-
quenced isolates were clustered (see “Methods”) based on 
their genotypes in order to assess their performance into 
three groups: genetically-identical where clones share 
identical genotypes; genetically-similar based on shared 
mutations (an expected outcome as multiple clones were 
isolated from the same population); and hyper-mutator 
isolates—which were eliminated from the secondary 
screening and further analysis. Overall, there were 3, 3, 
2, and 3 genetically-similar clusters for the MG1655/
[C4C1Im]Cl, DH1/[C4C1Im]Cl, MG1655/[C2C1Im][OAc], 
and DH1/[C2C1Im][OAc] conditions, respectively. Most 
of the clones showed reproducible performance when 
culturing. Results for both E. coli K-12 MG1655 and 
DH1 are summarized in Additional file 2: Tables S2 and 
S3, respectively. A few isolates did not grow during the 
secondary screen for unknown reasons (Additional file 2: 
Table S5).
Isolated strains from the study with similar genotypes 
exhibited a similar performance when tolerating ILs. A 
main difference in this study was that the growth rate cri-
terion was used to quantify strains with improved perfor-
mance. The coefficients of variation in growth rate  (h−1) 
between isolates that were genetically-identical or genet-
ically-similar were 21 and 11%, respectively. Some of the 
resequenced isolates exhibited no growth (6 out of 45 
clones, 4 with similar genotypes, Additional file 1). This 
non-growth could be a result of moving from unstressed 
to a highly-stressed condition during the screen, but 
it was not explored further. A more detailed analysis of 
the secondary screening results is provided in Additional 
file  2. The most promising isolates (based on criteria in 
Additional file 2: Figure S2) from each genetically identi-
cal or similar cluster were selected for further testing and 
are provided in Table 3.
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Tolerance testing of the selected evolved strains 
and comparison to previous work
Fifteen isolates selected from the secondary screen 
results (Table  3) were tested for tolerance to  [C2C1Im]
[OAc], an ionic liquid with arguably the best characteris-
tics for lignocellulose solubilization and pretreatment [5]. 
This screen was performed to establish quantitative dif-
ferences in final cellular densities achieved in batch cul-
ture (Fig.  2) and to understand cross-tolerance to other 
imidazolium-based ILs.
While almost all the isolates were capable of growth 
in M9 minimal medium in the presence of 4.3% (w/v) 
(250  mM)  [C2C1Im][OAc] (Fig.  2a), a few isolates had 
significantly higher final densities in this condition. 
These high performing isolates were three K-12 MG1655 
(MG 4.7, MG 3.10, and MG 4.5) and two DH1 (DH 5.10 
and DH 15.2) derivatives. Interestingly, only one of the 
five best performers were actually evolved on  [C2C1Im]
[OAc], DH1 15.2, while the remainder were isolated 
from the  [C4C1Im]Cl evolutions. Furthermore, increased 
Table 3 Selected clones from  each genetically identical or similar cluster were selected for  testing for  tolerance 
to  [C2C1Im][OAc] and  [C4C1Im]Cl ionic liquids
Each of the TALE-derived isolates is presented with the corresponding IL-type and concentration in which it was originally evolved along with phenotypic 
characteristics of each of the selected isolates
TALEs IL type Concentration (%) Gene set Aver. growth rate  (h−1) Aver. final  OD600 Aver. lag‑time (h)
MG 4.7 [C4C1Im]Cl 5.4 MG-BM-3A 0.26 ± 0.024 0.87 ± 0.039 4.88 ± 0.04
MG 3.10 [C4C1Im]Cl 5.4 MG-BM-3D 0.31 ± 0.009 0.94 ± 0.04 10.85 ± 1.24
MG 4.5 [C4C1Im]Cl 5.4 MG-BM-3E 0.30 ± 0.015 0.84 ± 0.082 3.19 ± 1.17
MG 11.10 [C2C1Im][OAc] 4.6 MG-EM-1 0.23 ± 0.003 1.69 ± 0.004 1.55 ± 0.006
MG 12.7 [C2C1Im][OAc] 4.6 MG-EM-1 0.27 ± 0.005 1.1 ± 0.03 1.9 ± 0.015
MG 10.9 [C2C1Im][OAc] 4.6 MG-EM-1A 0.09 ± 0.003 0.74 ± 0.004 1.99 ± 0.006
DH1 5.3 [C4C1Im]Cl 4.6 DH-BM-3A 0.32 ± 0.005 0.96 ± 0.01 12.51 ± 0.075
DH1 5.10 [C4C1Im]Cl 4.6 DH-BM-2 0.58 ± 0.023 0.61 ± 0.12 8.8 ± 1.059
DH1 6.7 [C4C1Im]Cl 4.6 DH-BM-1 0.36 ± 0.033 0.99 ± 0.094 5.62 ± 0.154
DH1 7.5 [C4C1Im]Cl 4.6 DH-BM-1 0.25 ± 0.025 1.39 ± 0.014 11.49 ± 3.604
DH1 13.10 [C2C1Im][OAc] 4.2 DH-EM-2A 0.14 ± 0.013 0.52 ± 0.385 9.59 ± 0.66
DH1 14.2 [C2C1Im][OAc] 4.2 DH-EM-2B 0.2 ± 0.027 0.36 ± 0.304 4.91 ± 1.083
DH1 13.8 [C2C1Im][OAc] 4.2 DH-EM-1 0.23 ± 0.007 0.6 ± 0.085 8.57 ± 3.393
DH1 15.2 [C2C1Im][OAc] 4.2 DH-EM-3C 0.28 ± 0.057 0.57 ± 0.148 6.33 ± 0.259
DH1 16.7 [C2C1Im][OAc] 4.2 DH-EM-3A 0.31 ± 0.014 0.26 ± 0.172 5.34 ± 0.44
Fig. 2 Performance of evolved clones in batch culture under M9 minimal media conditions with various  [C2C1Im][OAc] IL loadings. Shown is the 
final optical density  (OD600nm) of the selected best performing clones (Table 3) under different concentrations of  [C2C1Im][OAc]: a first, a screen 
with 250 mM and all best performing clones, b second, a follow up screen with 300, 500 and 700 mM utilizing the highest final density clones from 
the 250 mM screen. Surprisingly, a number of clones that were originally evolved for  [C4C1Im]Cl tolerance showed high cross-tolerance to elevated 
 [C2C1Im][OAc] concentrations. At the highest concentration (700 mM), only the MG1655 derived strains showed measurable growth
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amounts of  [C2C1Im][OAc] were tested with the five 
best performing isolates (Fig. 2b). Increasing amounts of 
IL inhibited growth in all the strains, but robust growth 
(i.e., a final  OD600 > 0.5) was detected for all five clones 
at 8.5% (w/v) IL and detectable growth was observed for 
the MG clones, MG 4.7, MG 3.10, and MG 4.5, in con-
centrations up to approximately 11.9% (w/v) (700  mM) 
 [C2C1Im][OAc] (Fig.  2b). These tests demonstrated that 
the evolved isolates display cross tolerance to ILs which 
they were not exposed to during the ALE process and the 
levels of IL tolerated were impressive when compare to 
previously-developed strains.
The final concentration of ILs tolerated by evolved iso-
lates using TALE were compared to previously reported 
strains generated for IL tolerance (Table  4). The robust 
growth of the best performing clones MG 4.7, MG 3.10, 
DH 5.10 and DH 15.2 observed at 8.5% (w/v) compares 
favorably with other reported values for engineered and 
evolved strains. For example, the tolerance achieved from 
[12] was based on introducing a mutation in the tran-
scriptional regulator encoded by rcdA with tolerance 
up to 3% (w/v)  [C2C1Im][OAc] achieved in LB medium. 
Additionally, thermophilic communities have been iso-
lated by enriching them for tolerance to  [C2C1Im][OAc], 
which has resulted in the identification of a mixed popu-
lation tolerant to 6% w/v  [C2C1Im][OAc] [10]. Finally, 
an ALE approach had also been previously employed to 
develop a strain tolerant to  [C4C1Im]Cl of approximately 
7% (w/v) in rich media (LB) [11]. A direct experimental 
comparison to two previously developed strains was also 
conducted.
Comparison of selected evolved strains 
to previously‑developed tolerant strains
The best performing IL tolerant isolates, MG 4.7 and MG 
3.10, were compared to rationally-engineered IL tolerant 
strains, JBEI-10101 [8] and JBEI-13314 [12], to provide a 
direct comparison for the efficacy of the evolution pro-
cess as compared to rational engineering approaches. 
JBEI-10101 [8] is DH1 harboring a plasmid containing 
genes for an MFS-1 pump from Enterobacter lignolyticus 
and its response regulator (eilAR), and the JBEI-13314 
[12] is DH1 carrying a deletion in rcdA, which encodes 
a predicted transcriptional regulator of the MFS-1 pump 
ybjJ. Two different media types were used in this compar-
ison: a rich undefined LB medium and a minimal defined 
M9-glucose medium. This comparison was performed 
using two different promising IL compounds, 300 mM of 
either  [C2C1Im][OAc] [5.1% (w/v)] or  [C2C1Im][Cl] [4.4% 
(w/v)].  [C2C1Im][Cl] which contains a chloride anion, 
was found to be effective towards dissolving cellulose in 
comparison to larger anions,  [C2C1Im][OAc] [43]. Fur-
thermore, ILs with anions such as acetate (e.g.,  [C2C1Im]
[OAc]) have lower viscosities and this is beneficial as it 
facilitates the dissolution process [9].
The performance of the TALE derived strains was 
superior to those developed through rational engineer-
ing. In LB medium at 300  mM of  [C2C1Im][OAc] or 
 [C2C1Im]Cl, the performance of JBEI-13314 and JBEI-
10101 was improved over the background control of a 
wild-type MG1655. In the same conditions, the TALE-
derived strains, MG 4.7 and MG 3.10, grew at a signifi-
cantly faster rate and to a higher final density than the 
Table 4 Comparison of IL tolerance in the generated TALE evolved strains in the current study and previously reported 
tolerances from different studies with each respective tolerant biological system
The high performing isolates from this work were three K-12 MG1655 mutants (MG 4.7, MG 3.10, and MG 4.5) and two DH1 mutants (DH 5.10 and DH 15.2)
Strain IL’s type Description/mechanism Culturing environment Concentration % (w/v) 
criteria
References
E. coli K-12 MG1655 ∆fadD 
mutant
[C4C1Im]Cl ALE (90 days long) LB broth 7.0 [11]
E. coli DH1 [C2C1Im]Cl Efflux pump encoded by 
eilA from Enterobacter 
lignolyticus
Minimal media (M9) 5.8 [9]
JBEI-10101 (E. coli DH1) [C2C1Im]Cl Native eilA pump from 
Enterobacter lignolyticus
Minimal media (M9) 5.5 [8]
Thermophilic communities [C2C1Im][OAc] Thermophilic enrichment Raw material with minimal 
media
6.0 [10]
JBEI-13314 (E. coli DH1 rcdA 
mutant)
[C2C1Im][OAc] Mutation of transcriptional 
regulator encoded by rcdA
LB broth 3.0 [12]
E. coli K-12 MG1655 mutants 
MG4.7, MG 3.10, and MG 
4.5
[C2C1Im][OAc] TALE isolate Minimal media (M9) 8.5 This work
E. coli DH1 mutants DH 5.10 
and 15.2
[C2C1Im][OAc] TALE isolate Minimal media (M9) 8.5 This work
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rationally engineered strains. Specifically, the TALE 
derived strain, MG 4.7, grew to a final  OD600 of approxi-
mately 3.0 and 1.5 in LB containing  [C2C1Im][OAc] and 
 [C2C1Im]Cl, respectively, versus final ODs of approxi-
mately 1.0 on both ILs for the best performing ration-
ally engineered JBEI-10101 strain. Similarly, the growth 
rates were higher for the TALE-derived strains (Fig.  3a, 
b). It should be noted that the TALE-derived strains had 
not been evolved in LB, whereas the JBEI strains were 
benchmarked in LB (or similar rich medium) as a base 
medium [8, 12]. Further, in M9 glucose medium contain-
ing 300 mM  [C2C1Im][OAc] or 300 mM  [C2C1Im]Cl, the 
final cell biomass,  OD600, values reached were approxi-
mately, 1.5 and 4.0 for MG 4.7 and 1.0 and 3.0 for MG 
3.10 in  [C2C1Im][OAc] and  [C2C1Im]Cl, respectively 
(Fig.  3c, d), whereas JBEI-13314 and JBEI-10101 exhib-
ited virtually no detectable growth.
The tolerance phenotypes demonstrated by the TALE-
derived isolates gives a strong indication of the causal-
ity of the mutations identified in this work, specifically, 
the ‘combined’ key mutations (Table 2). Both the MG 4.7 
and MG 3.10 were found to carry ten mutations each, 
eight being identical and shared, and several mutations 
were from the combined key mutation set. Namely, MG 
4.7 and MG 3.10 share a ∆120  bp deletion in the inter-
genic region between mdtJ/tqsA and 12  bp deletion in 
tqsA. Both strains also carry an additional key mutation, 
a coding SNP in rpoC. Further, they both carry different 
frameshift mutations in the yhdP gene. Differentiating 
key mutations are a ∆1 bp deletion in rpsG in MG 3.10 
isolate, and a coding SNP in rpsA in MG 4.7, with both 
genes encoding ribosomal protein subunits.
The best performing DH1 isolates, DH1 5.10 and DH1 
15.2, also shared key mutations. Each isolate possessed 
seven mutations overall, none of them identical between 
the isolates. However, shared genes that were mutated 
included coding SNPs in the rho gene. Other strain-spe-
cific key mutations were identified in the strains includ-
ing SNPs in purB and cspC identified in DH1 5.10 and 
a frameshift insertion mutation in fhuA in DH1 15.2. It 
should be noted that the gene encoding the regulator of 
purB, purR [44], carried a mutation in the isolate that did 
Fig. 3 Comparison of TALE evolved IL tolerant clones MG1655#4.7 and MG1655#3.10 to previously engineering tolerant strains JBEI-13314 and 
JBEI-10101 in LB (a, b) and M9 (c, d) media containing either 300 mM of  [C2C1Im][OAc] [5.1% (w/v)] or  [C2C1Im][Cl] [4.4% (w/v)]. TALE evolved clones 
exhibited improved growth compared to rationally-designed strains, particularly in M9, where JBEI-13314 and JBEI-10101 were severely inhibited
Page 12 of 15Mohamed et al. Microb Cell Fact  (2017) 16:204 
not possess a direct mutation in purB. Thus, the muta-
tions identified as key in Table  2 can be linked to high 
performing phenotypes and are likely causal. However, 
detailed studies to reveal their mechanism of causality 
are required.
Discussion
The economical and efficient break down of lignocellu-
losic material into carbon feedstocks is an essential step 
in renewable bioprocessing. Ionic liquid (IL) solubiliza-
tion is a promising method for breakdown of lignocel-
lulosic material, however these compounds are toxic to 
most bioproduction chassis strains. Thus, the scope of 
this study was to generate IL tolerant strains utilizing 
an adaptive laboratory evolution process. Accordingly, 
the main contributions from this work are: (1) effective 
generation of IL tolerant strains (including cross-toler-
ance) for two common production chassis, E. coli K-12 
MG1655 and DH1, which can be used as platform strains 
for utilizing feedstocks generated through IL degradation 
methods, (2) insights into both strain-specific and global 
mechanisms of IL tolerance through examining key 
mutations found in multiple parallel evolved isolates, and 
(3) establishing a viable method using a multiple popu-
lation TALE approach with next-generation sequencing 
towards generating tolerant strains. This method was 
benchmarked via comparison to rational engineering 
approaches.
TALE was successful in generating strains that were 
tolerant to the targeted ILs. After approximately 40 days 
of continuous exposure to ILs during growth (mostly in 
exponential growth), populations of cells were able to 
grow at approximately threefold or greater of the ini-
tial concentration of each IL compared to the wild type 
(Table 1). Tolerance levels of isolated clones are impres-
sive when compared to other tolerant bacterial strains [8, 
12, 45]. Additionally, the selected best performing strains 
demonstrated high level of IL cross-tolerance toward 
 [C2C1Im][OAc]; detectable growth at 11.9% (w/v) for 
TALE-derived E. coli K-12 MG1655 clones and robust 
growth at 8.5% (w/v) for the same MG1655 isolates plus 
the E. coli DH1 best-performing clones. Thus, the TALE-
derived strains show promise as platform strains for 
utilization of biomass hydrolysates generated using IL 
treatment.
The key mutations identified from this study provide 
insights into the potential mechanisms of tolerance phe-
notypes in the evolved strains. The most prevalent and 
shared mutations observed were in the mdtJ/tqsA inter-
genic region, as well as in the tqsA gene, and in the yhdP 
gene (Fig.  4). The key mutations identified in this study 
were specific to ILs when compared to a control experi-
ment where K-12 MG1655 was evolved on M9 glucose 
minimal medium at the same temperature but without 
any stress from ILs [17]. Thus, it appears that modulat-
ing transport, likely of ILs, in and out of the cell is cru-
cial for tolerance to the ILs tested here and likely similar 
compounds. This finding further supports the focus of 
rationally modulating transport systems in engineering 
tolerance [12, 23, 46]. However, identifying which trans-
porters are critical for tolerance in a given strain de novo 
is difficult, therefore making the use of TALE a powerful 
approach.
A genetic-level analysis of the specific multidrug trans-
port system mutation observed in both strains provides 
a glimpse into the mechanistic impact of these muta-
tions. The most prevalent Δ120 bp deletion in the inter-
genic region between mdtJ and tqsA likely disrupts H-NS 
binding sites in the mdtJI promotor region, which is then 
believed to relieve negative repression of transcription of 
mdtJI by H-NS, given its role as a steric hindrance pro-
tein [47]. Supporting this, when H-NS is absent, a nine-
fold increase in mdtJI expression occurs as compared to 
wild type E. coli, and consequently the activity of MdtJI as 
well [47]. This finding further highlights the likely active 
role of this small multi-drug resistance (SMR) efflux 
pump in the resistance mechanism. Similar work has 
shown such pumps to be active on a wide range of inhibi-
tory compounds [23, 46–48]. It is noteworthy that in the 
control experiment [17], an intergenic hns/tdk mutation 
was reported in almost all evolved endpoints where hns 
was determined to be upregulated and conferred a fit-
ness advantage, i.e., fast growth rate, likely through sub-
sequent downregulation of stress responses. Given that 
no similar intergenic hns/tdk mutations were seen in this 
work with ILs present during the evolution, this finding 
further supports the importance of high expression of 
mdtJI towards tolerance of the ILs examined here and the 
benefit of control ALE experiments.
The other key mutated region, in this case one gene, 
identified in the tolerant clones was in yhdP. The yhdP 
gene encodes a predicted transporter [29]. The occur-
rence of five unique mutations, all interpreted to be loss 
of function mutations, imply that removing this gene is 
a viable strategy for increased IL tolerance. However, the 
specific mechanism is unclear as to what metabolite is 
pumped in or out of the cell to provide the increased fit-
ness. One can speculate that ILs could enter through this 
transporter, but this has yet to be verified. Future work 
could include an effort to definitively assign the causality 
of key mutations. For example, expression profiling could 
be performed on isolates or reconstructed strains car-
rying only the Δ120 bp deletion in the intergenic region 
between mdtJ and tqsA. Such transcription levels could 
help focus on the impact of mdtJ and/or tqsA and lead to 
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a better understanding of the underlying mechanisms of 
tolerance.
The TALE approach of independently passaging multi-
ple populations in an automated, strictly-controlled plat-
form, coupled with next-generation sequencing resulted 
in an effective process for generating tolerant strains 
and for revealing the key causal mutations. Sequencing 
the whole genome revealed mutational changes in the 
evolved strains when compared to the reference strains. 
However, relating a specific mutation or a set of muta-
tions, i.e., genotype, to the apparent phenotype in cer-
tain conditions is time-consuming [39, 49, 50]. The use 
of multiple independent replicates allowed for the iden-
tification of mutations in the same gene or genetic region 
multiple times across different TALE experiments. This 
approach of using many replicates to decipher the cau-
sality of a mutation or set of mutations in a given strain 
appeared effective given that the best performing clones, 
MG4.7 and MG3.10, possessed such key shared muta-
tions. To validate the key mutations identified, as well 
as to confirm the efficacy of the evolution process, the 
selected clones were compared to rationally-designed 
strains in two different media with closely similar ILs. 
The performance of TALE-derived strains was supe-
rior, which indicated the efficacy of utilizing TALE and 
pointed to the identified mutations in the generated the 
strains.
In summary, utilizing the TALE approach outlined here 
to generate IL-tolerant strains resulted in the generation 
of promising platform strains with enhanced tolerance 
toward high concentrations of ILs [up to 11.9% (w/v)]. 
The approach used to identify and interpret the key 
causal mutations using whole genome sequencing com-
plemented with analyzing isolates from multiple inde-
pendent populations, and multiple isolates from each 
population, was successful in revealing the key mutations 
involved in IL tolerance phenotypes. The most striking 
identified key mutations appeared to involve modula-
tion of transport mechanisms, possibly the direct trans-
port of ILs into and out of the cell. The results of this 
study and the approach used to generate tolerant strains 
can be expanded to other conditions, strains, and selec-
tion criteria, which would help in fast-tracking the utili-
zation of alternative renewable feedstocks, as well as to 
Fig. 4 A diagram of the cell showing processes associated with key mutations. A cartoon diagram of key mutations in potential causal genetic 
regions identified in the evolved strains. A total of eight mutations are represented amongst different genetic regions. A Δ120 bp deletion was 
found in the non-coding region of mdtJ, near the promoter, and its neighboring gene tqsA. Two other structural changes were found in the tqsA 
gene—one was an intragenic in-frame Δ12 bp deletion, the other was a Δ3035 bp deletion which included a major section of tqsA and the pntB 
and pntA genes located next to tqsA on the chromosome. Finally, five structural changes were identified in yhdP gene. These were two out-of-frame 
short deletions (Δ2 bp and Δ4 bp), two intergenic IS mobile element insertions, and a short 7 bp insertion/duplication. These mutations indicate a 
probable loss-of-function of yhdP
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better understand tolerance mechanisms for inhibitory 
compounds.
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